Search results

Evidence-based recommendations on empagliflozin (Jardiance) in combination therapy for treating type 2 diabetes.

Result type

Technology appraisal guidance

Published

25 March 2015

Evidence-based recommendations on canagliflozin (Invokana) in combination therapy for treating type 2 diabetes in adults.

Result type

Technology appraisal guidance

Published

25 June 2014

Summary of the evidence on insulin degludec for treating type 2 diabetes to inform local NHS planning and decision-making

Result type

Evidence summary

Published

10 September 2013

Evidence-based recommendations on ertugliflozin (Steglatro) with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes in adults.

Result type

Technology appraisal guidance

Published

5 June 2019